Gsk (GSK) Accounts Payables (2009 - 2026)
Gsk (GSK) posted Accounts Payables of $20.5 billion for Q4 2025, up 3.95% on a QoQ basis from $19.7 billion in Q4 2024, and up 3.95% year-over-year from $19.7 billion in Q4 2024.
Gsk (GSK) has 10 years of Accounts Payables data on file, last reported at $20.5 billion in Q4 2025.
- In Q4 2025, Accounts Payables rose 3.95% year-over-year to $20.5 billion; the TTM figure through Dec 2025 stood at $20.5 billion (up 3.95% YoY), while the FY2025 annual figure was $20.5 billion, up 3.95% from the prior year.
- Accounts Payables rose to $20.5 billion in Q4 2025, from $19.7 billion in the prior quarter.
- Across five years, Accounts Payables topped out at $23.7 billion in Q4 2021 and bottomed at $19.1 billion in Q4 2022.
- A 5-year average of $20.5 billion and a median of $19.7 billion in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2021 — Accounts Payables advanced 13.13% — and 2022, when it dropped 19.39%.
- Year by year, Accounts Payables stood at $23.7 billion in 2021, then fell by 19.39% to $19.1 billion in 2022, then rose by 3.09% to $19.7 billion in 2023, then climbed by 0.09% to $19.7 billion in 2024, then rose by 3.95% to $20.5 billion in 2025.
- The last three Accounts Payables figures came in at $20.5 billion (Q4 2025), $19.7 billion (Q4 2024), and $19.7 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.03 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 10.46 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 33.77 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 3.86 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.94 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 645.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 4.51 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 4.23 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 20.46 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.33 Bn |
| Dec 31, 2025 | -20.46 Bn |
| Sep 30, 2025 | -21.15 Bn |
| Jun 30, 2025 | -19.77 Bn |
| Mar 31, 2025 | -19.08 Bn |
| Dec 31, 2024 | 19.68 Bn |
| Sep 30, 2024 | -18.68 Bn |
| Jun 30, 2024 | -17.98 Bn |
| Mar 31, 2024 | -18.55 Bn |
| Dec 31, 2023 | 19.66 Bn |
| Sep 30, 2023 | -19.74 Bn |
| Jun 30, 2023 | -17.46 Bn |
| Mar 31, 2023 | -17.34 Bn |
| Dec 31, 2022 | 19.08 Bn |
| Sep 30, 2022 | -18.99 Bn |
| Jun 30, 2022 | -18.65 Bn |
| Mar 31, 2022 | -4.22 Bn |
| Dec 31, 2021 | 23.66 Bn |
| Sep 30, 2021 | -21.00 Bn |
| Jun 30, 2021 | -19.94 Bn |
| Mar 31, 2021 | -20.15 Bn |
| Dec 31, 2020 | 20.92 Bn |
| Jun 30, 2020 | -19.18 Bn |
| Mar 31, 2020 | -19.63 Bn |
| Dec 31, 2019 | 19.21 Bn |
| Sep 30, 2019 | -18.17 Bn |
| Jun 30, 2019 | -17.22 Bn |
| Mar 31, 2019 | -17.48 Bn |
| Dec 31, 2018 | 18.06 Bn |
| Sep 30, 2018 | -17.07 Bn |
| Jun 30, 2018 | -17.09 Bn |
| Mar 31, 2018 | -29.33 Bn |
| Dec 31, 2017 | 4.68 Bn |
| Sep 30, 2017 | -25.96 Bn |
| Jun 30, 2017 | -25.02 Bn |
| Mar 31, 2017 | -14.91 Bn |
| Dec 31, 2016 | 14.87 Bn |
| Sep 30, 2016 | -14.78 Bn |
| Jun 30, 2016 | -14.97 Bn |
| Mar 31, 2016 | -14.85 Bn |
| Dec 31, 2015 | -13.48 Bn |
| Sep 30, 2015 | -13.20 Bn |
| Jun 30, 2015 | -12.48 Bn |
| Mar 31, 2015 | -13.03 Bn |
| Dec 31, 2014 | -12.61 Bn |
| Sep 30, 2014 | -12.61 Bn |
| Jun 30, 2014 | -11.69 Bn |
| Mar 31, 2014 | -12.08 Bn |
| Dec 31, 2013 | -13.47 Bn |
| Sep 30, 2013 | -12.08 Bn |
| Jun 30, 2013 | -12.03 Bn |
| Mar 31, 2013 | -11.99 Bn |
| Dec 31, 2012 | 390.23 Mn |
| Sep 30, 2012 | -12.13 Bn |
| Jun 30, 2012 | -11.34 Bn |
| Mar 31, 2012 | -11.09 Bn |
| Dec 31, 2011 | 391.32 Mn |
| Sep 30, 2011 | -11.55 Bn |
| Jun 30, 2011 | -11.85 Bn |
| Mar 31, 2011 | -11.60 Bn |
| Dec 31, 2010 | -10.88 Bn |
| Sep 30, 2010 | -10.55 Bn |
| Jun 30, 2010 | -9.80 Bn |
| Mar 31, 2010 | -10.61 Bn |
| Dec 31, 2009 | -11.06 Bn |
| Sep 30, 2009 | -9.98 Bn |
| Jun 30, 2009 | -7.99 Bn |
| Mar 31, 2009 | -8.27 Bn |